RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Exo Therapeutics

Exo Therapeutics

Building a new discovery paradigm to unlock intractable drug targets with exosites

Latest funding

$78M Series B+ ·

Led by Nextech Invest · Source: fundraisingfox.com

Total raised: $103M across 2 sourced rounds

All 2 rounds ↓
X: @ExoTherapeutics · 201 followers.
LinkedIn: exorx.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Pharmaceutical.
Stage: Series B+.
Based in: Cambridge, United States.
Founded: 2018.
Total raised: $103M in 2 sourced rounds.
Last round: Oct 5, 2021 · 1,868 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@ExoTherapeutics · created Dec 7, 2020 (5 years old) · 201 followers
Website registeredDec 14, 2018 (7 years old)
TIMELINE · MONEY RAISED

Exo Therapeutics | 733 days from website to first raise on record

@ExoTherapeutics·Raised $103M in 2 sourced rounds·2 signals before the first raise
$26M$52M$77M$103MJAN 2019FEBMARAPRMAYJUNJULAUG$103M||WEBSITE CREATED · DEC 14, 2018||X ACCOUNT CREATED @EXOTHERAPEUTICS · DEC 7, 2020$25M Series A · Dec 16, 2020$25M A · DEC '20$78M Series B+ · Oct 5, 2021$78M B+ · OCT '21

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$78MNNextech Investfundraisingfox.com
Series A$25MNNewpath Managementexo-therapeutics.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like Exo Therapeutics

Other companies backed by Nextech Invest

Nextech Invest portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/exo-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy